Mainz Biomed today acquired the exclusive rights to a portfolio of novel mRNA biomarkers. Investors cheered the announcement to help the company’s ColoAlert colorectal cancer test become the leadi

Key points: Oracle Power just released the maiden drilling results from the Nothern Zone Gold Project in Western Australia. The results were impressive, and the miner is planning to star

Exicure has been something of a disaster, stockholders have lost 90% of their money since the IPO Finding that a leading researcher was being less than ope

Wejo is a British company quoted on NASDAQ and in the connected car space Wejo came to market through the SPAC route, not an IPO, in November As a result analyst coverage on Wejo has been scant but this is improvin

Key points: Oxford Biomedica just signed a licensing agreement with Cabaletta Bio. The deal will generate revenues for the company over multiple years. Investo

Key points: Myhealthchecked just signed a distribution deal with Lloyds Pharmacy. The deal will see Lloyds Pharmacy exclusively sell its Fit to Fly rapid COVID-19 antigen tests.

Avacta had a good - 30% - boost to its share price when it announced it had received a CE Mark for its covid test The big question was whether this jump in the share price would stick or fade So far that leap seems

Key points: ValiRx just signed a service agreement with TheoremRx, the firm looking to sub-license its VAL201 drug molecule. The agreement guarantees that ValiRx will be paid for all the

Lynas Corporation has a good story behind it - the only major rare earths processor outside China Lynas’ position may or may not survive the wave of invest

AJ Bell estimates that Metro Bank is valued at only 13% of assets The major High Street banks however are priced at some 80% of assets

  Analysts point out the unique position of Riot as exposure to the cryptocurrency market A recent increase in hash rate further bolsters the company's mining operations Not e

Disney+ attendance is expected to return by Q422 Content spending is set to increase by $8B to manage expectations Wells Fargo argue Disney is well-positioned as a 'large-cap growth stock' for 2022

Fords' F-150 Lightning truck is in high demand ahead of its Spring release Plans to double production levels came ahead of GM'S electric pickup reveal Things are looking positive for Ford's EV growth in 2022

Key points: Plus Therapeutics stock spiked 65.9% higher after achieving two crucial milestones. Investors cheered the milestones that brought its RNL drug closer to commercialisation.

Key points: Soligenix stock rallied higher on non-clinical data about dusquetide. The new data highlighted dusquetide’s effectiveness against cancers. However,

Key points: Carnival plc shares started the year gapping up 8.96% to catch up with its US shares. The cruise ship operator has positive prospects if its operations are not halted.

AMD has forever been the runner up in the microprocessor race Given the general global problems with supplies of processors AMD’s time might well have come

Zinnwald Lithium’s share price has suffered from the recent placing and dilution There was also the overhang of Solarworld’s stake to depress the price

IAG is up near 10% this morning on the fading of omicron fears Wizz Air is also up the same amount for the same reason

In the short term, no, Apple’s $3 trillion valuation didn’t last, the stock slipped back In the medium term, it depends upon iPhone sales continuing to mot